Back to Search
Start Over
Potential anti-alopecia constituents from Theobroma cacao: An in silico study
- Source :
- Journal of Advanced Pharmaceutical Technology & Research, Vol 12, Iss 2, Pp 169-174 (2021), Journal of Advanced Pharmaceutical Technology & Research
- Publication Year :
- 2021
- Publisher :
- Wolters Kluwer Medknow Publications, 2021.
-
Abstract
- Tinea capitis is local alopecia caused by a dermatophyte infection of the scalp. Trichophyton rubrum produces the squalene epoxidase enzyme, which has a crucial role in prolonged dermatophyte infection, as well as in synthesizing fatty acids in this dermatophyte group. This study analyzes Trichophyton cacao compounds as anti-alopecia by inhibiting the squalene epoxidase enzyme formation, in silico. The structure of T. cacao compounds was prepared using the MolView Web application. The compound docked to squalene epoxidase using AutoDock Vina in PyRx 0.8, followed by PyMOL for visualization, and the Proteins Plus program to analyze the complexity. The binding affinity value of catechin, epicatechin (−8.0 kcal/mol), and anthocyanin (−7.8 kcal/mol) compounds was higher than the positive control (terbinafine, −6.7 kcal/mol). Pre-ADMET demonstrated that catechin and epicatechin had moderate Human Intestinal Absorption (66.71%), but anthocyanin was very good (100%). Caco-2 parameters for catechin and epicatechin were relatively low (
- Subjects :
- Squalene monooxygenase
Trichophyton rubrum
RM1-950
medicine.disease_cause
chemistry.chemical_compound
Pharmacy and materia medica
trichophyton rubrum
medicine
Theobromine
chemistry.chemical_classification
biology
Chemistry
tinea capitis
Catechin
biology.organism_classification
alopecia
RS1-441
Enzyme
Biochemistry
Dermatophyte
Lipinski's rule of five
Terbinafine
squalene epoxidase
Original Article
Therapeutics. Pharmacology
trichophyton cacao compounds
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 09762094 and 22314040
- Volume :
- 12
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Journal of Advanced Pharmaceutical Technology & Research
- Accession number :
- edsair.doi.dedup.....5234b1dbe94c846aa051b144bde03a70